| DIANTHUS THERAPEUTICS |
| USA |
| Gesundheit |
| US2528281080 / A3ERZ4 |
| 87E (Frankfurt) / DNTH (NASDAQ) |
| FRA:87E, ETR:87E, 87E:GR, NASDAQ:DNTH |
| - |
| https://dianthustx.com/ |
|
Dianthus Therapeutics Inc. is a biotechnology company focused on discovering and developing precision medicines for patients with severe autoimmune and inflammatory diseases. At the core of its missio..
>Volltext.. |
| 2425.61 Mio. EUR |
| 2083.88 Mio. EUR |
| 2.65 Mio. EUR |
| -120.41 Mio. EUR |
| -108.75 Mio. EUR |
| -3.01 EUR |
| 1.11 Mio. EUR |
| 48.19 Mio. EUR |
| -94.27 Mio. EUR |
| 16.88 |
| -45.57% |
| -78.68% |
| - |
| - |
| - |
| - |
| DIANTHUS |
| 09.03.26 |
|